Please ensure Javascript is enabled for purposes of website accessibility

United Therapeutics posts loss

United Therapeutics Corp., a Silver Spring-based biotechnology company, reported a net loss of $25.2 million, or 53 cents per share, for the quarter ended Sept. 30. In the same quarter of 2013, United Therapeutics posted net income of $62.7 million, or $1.25 per basic share. Revenues for the 2014 quarter were $330.0 million, up from $302.2 million for 2013 period.